Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Open Label Study of the Efficacy and Safety of Tudca in Ulcerative Colitis

NCT04114292 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04114292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04114292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Open Label Study of the Efficacy and Safety of Tudca in Ulcerative Colitis
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
January 17, 2019
Completion date
June 7, 2022
Enrollment
14 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis